within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BX02_Repaglinide;

model Repaglinide
  extends Pharmacolibrary.Drugs.ATC.A.A10BX02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BX02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Repaglinide is an oral antihyperglycemic agent of the meglitinide class used to manage type 2 diabetes mellitus by stimulating insulin secretion from the pancreas. It is approved and widely used today for glycemic control in adults with type 2 diabetes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers, single-dose administration, both sexes, age 18-60.</p><h4>References</h4><ol><li><p>Ruzilawati, AB, &amp; Gan, SH (2010). CYP3A4 genetic polymorphism influences repaglinide&#x27;s pharmacokinetics. <i>Pharmacology</i> 85(6) 357–364. DOI:<a href=\"https://doi.org/10.1159/000302731\">10.1159/000302731</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20523106/\">https://pubmed.ncbi.nlm.nih.gov/20523106</a></p></li><li><p>Kirchheiner, J, et al., &amp; Brockmöller, J (2005). Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance. <i>Clinical pharmacokinetics</i> 44(12) 1209–1225. DOI:<a href=\"https://doi.org/10.2165/00003088-200544120-00002\">10.2165/00003088-200544120-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16372821/\">https://pubmed.ncbi.nlm.nih.gov/16372821</a></p></li><li><p>He, J, et al., &amp; Chen, X (2011). Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers. <i>European journal of clinical pharmacology</i> 67(7) 701–707. DOI:<a href=\"https://doi.org/10.1007/s00228-011-0994-7\">10.1007/s00228-011-0994-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21327909/\">https://pubmed.ncbi.nlm.nih.gov/21327909</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Repaglinide;
